Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Spannagl

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
Annals of Hematology|August 1, 1992
Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosusT Sitter, M Spannagl, H Schiffl
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
A new AT III-heparin-complex preparation: in vitro and in vivo characterisationM Spannagl, R Keller, W Schramm
Der Anaesthesist|October 14, 2009
[Perioperative management of patients with coronary stents in non-cardiac surgery]C Jámbor, M Spannagl, B Zwissler
Hamostaseologie|September 19, 2009
[Morbidity and mortality of patients with haemophilia in Germany 2007/2008]H Krebs, M Spannagl, W Schramm, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|August 16, 2000
Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?M Spannagl, L A Heinemann, W Schramm
Agents and Actions. Supplements|January 1, 1992
Effects of protease inhibitors in experimental septic shockM Siebeck, M Spannagl, H Hoffmann, et al.
Thrombosis and Haemostasis|July 1, 1994
High dose aprotinin reduces prothrombin and fibrinogen conversion in patients undergoing extracorporeal circulation for myocardial revascularizationM Spannagl, W Dietrich, A Beck, et al.
Progress in Clinical and Biological Research|January 1, 1989
Therapeutic effects of the combination of two proteinase inhibitors in endotoxin shock of the pigM Siebeck, H Hoffmann, J Weipert, et al.
Tissue Antigens|May 8, 2013
A novel HLA-A allele, A*66:17 was revealed in a family of a leukemia patient during high-resolution HLA typingK Witter, M Kutsch, M Spannagl, et al.
Thrombosis and Haemostasis|May 1, 1995
Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypassM Spannagl, G Dooijewaard, W Dietrich, et al.
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Annals of Hematology|August 1, 1992
Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosusT Sitter, M Spannagl, H Schiffl
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
A new AT III-heparin-complex preparation: in vitro and in vivo characterisationM Spannagl, R Keller, W Schramm
Der Anaesthesist|October 14, 2009
[Perioperative management of patients with coronary stents in non-cardiac surgery]C Jámbor, M Spannagl, B Zwissler
Hamostaseologie|September 19, 2009
[Morbidity and mortality of patients with haemophilia in Germany 2007/2008]H Krebs, M Spannagl, W Schramm, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|August 16, 2000
Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?M Spannagl, L A Heinemann, W Schramm
Agents and Actions. Supplements|January 1, 1992
Effects of protease inhibitors in experimental septic shockM Siebeck, M Spannagl, H Hoffmann, et al.
Thrombosis and Haemostasis|July 1, 1994
High dose aprotinin reduces prothrombin and fibrinogen conversion in patients undergoing extracorporeal circulation for myocardial revascularizationM Spannagl, W Dietrich, A Beck, et al.
Progress in Clinical and Biological Research|January 1, 1989
Therapeutic effects of the combination of two proteinase inhibitors in endotoxin shock of the pigM Siebeck, H Hoffmann, J Weipert, et al.
Tissue Antigens|May 8, 2013
A novel HLA-A allele, A*66:17 was revealed in a family of a leukemia patient during high-resolution HLA typingK Witter, M Kutsch, M Spannagl, et al.
Thrombosis and Haemostasis|May 1, 1995
Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypassM Spannagl, G Dooijewaard, W Dietrich, et al.
Pageof 13